Serum pyridinoline levels and prediction of severity of joint destruction in rheumatoid arthritis

Journal of Rheumatology

Volumn 40, Issue 8, 2013, Pages 1303-1306

  Krabben, Annemarie ^a   Knevel, Rachel ^a   Huizinga, Tom W J ^a   Cavet, Guy ^b   Van Der Helm Van Mil, Annette H M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Crescendo Bioscience Inc   (United States)

Author keywords

Biological marker; Collagen; Joint destruction; Rheumatoid arthritis

Indexed keywords

PYRIDINOLINE;

ADULT; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE COURSE; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; JOINT DESTRUCTION; JOINT RADIOGRAPHY; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; RHEUMATOID ARTHRITIS; SCORING SYSTEM; SHARP VAN DER HEIJDE SCORING;

BIOLOGICAL MARKER; COLLAGEN; JOINT DESTRUCTION; RHEUMATOID ARTHRITIS;

ADULT; AGED; AMINO ACIDS; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; JOINTS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REGRESSION ANALYSIS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 84881440864     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.121392     Document Type: Article

References (11)

1. de Rooy DP, van der Linden MP, Knevel R, Huizinga TW, van der Helm-van Mil AH. Predicting arthritis outcomes-what can be learned from the Leiden Early Arthritis Clinic? Rheumatology 2011;50:93-100.
2. Garnero P, Landewe R, Boers M, Verhoeven A, van der Linden S, Christgau S, et al. Association of baseline levels of markers of bone and cartilage degradation with long-term progression of joint damage in patients with early rheumatoid arthritis: the COBRA study. Arthritis Rheum 2002;46:2847-56.
3. Astbury C, Bird HA, McLaren AM, Robins SP. Urinary excretion of pyridinium crosslinks of collagen correlated with joint damage in arthritis. Br J Rheumatol 1994;33:11-5.
4. Black D, Marabani M, Sturrock RD, Robins SP. Urinary excretion of the hydroxypyridinium crosslinks of collagen in patients with rheumatoid arthritis. Ann Rheum Dis 1989;48:641-4.
5. Seibel MJ, Duncan A, Robins SP. Urinary hydroxy-pyridinium crosslinks provide indices of cartilage and bone involvement in arthritic diseases. J Rheumatol 1989;16:964-70.
6. Muller A, Jakob K, Hein GE. Evaluation of free and peptide bound collagen crosslink excretion in different skeletal diseases. Ann Rheum Dis 2003;62:65-7.
7. Le Loet X, Brazier M, Mejjad O, Boumier P, Daragon A, Gayet A, et al. Serum IgA rheumatoid factor and pyridinoline in very early arthritis as predictors of erosion(s) at two years: A simple model of prediction from a conservatively treated community-based inception cohort. Arthritis Care Res 2010;62:1739-47.
8. Jensen T, Klarlund M, Hansen M, Jensen KE, Skjodt H, Hyldstrup L. Connective tissue metabolism in patients with unclassified polyarthritis and early rheumatoid arthritis. Relationship to disease activity, bone mineral density, and radiographic outcome. J Rheumatol 2004;31:1698-708.
9. Hein G, Franke S, Muller A, Braunig E, Eidner T, Stein G. The determination of pyridinium crosslinks in urine and serum as a possible marker of cartilage degradation in rheumatoid arthritis. Clin Rheumatol 1997;16:167-72.
10. Knevel R, Krabben A, Brouwer E, Posthumus MD, Wilson AG, Saxne T, et al. Genetic variants in IL15 associate with progression of joint destruction in rheumatoid arthritis: a multicohort study. Ann Rheum Dis 2012;71:1651-7.
11. Visser K, Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Ronday HK, Seys PE, Kerstens PJ, et al. A matrix risk model for the prediction of rapid radiographic progression in patients with rheumatoid arthritis receiving different dynamic treatment strategies: Post hoc analyses from the BeSt study. Ann Rheum Dis 2010;69:1333-7.